Nautilus Biotechnology Inc

Penny Stocks Healthcare Stocks

$0.96

-0.03 (-2.81%)

As of Oct 3, 2:16 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +2,658.9% upside

Low Target $24.26

Average Target $26.56

High Target $41.87

Current Price $0.96

Current
$0.96

Target
$26.56

$24.26 $26.56 avg $41.87

Scenario Analysis

Bear Case

$24.26

2,420.0%

Low target

Base Case

$26.56

+2,658.9%

Avg target

Bull Case

$41.87

+4,249.2%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$4.31

-77.7% from high

52-Week Low

$0.82

+17.4% from low

Target vs 52W High

$26.56

+516.2% vs high

Peer Consensus — Life Sciences Tools & Services

Stock	Consensus	Analysts	Buy %	Target	Upside
TMO Thermo Fisher Scientific Inc	Strong Buy	36	81%	$369.21	-43.6%
DHR Danaher Corp	Strong Buy	32	84%	$158.11	-26.1%
A Agilent Technologies Inc	Strong Buy	30	77%	$64.69	-61.4%
WAT Waters Corp	Buy	31	65%	$189.60	-55.4%
IQV Iqvia Holdings Inc	Strong Buy	28	82%	$82.96	-67.9%
ILMN Illumina Inc	Buy	28	57%	$169.36	-38.0%
MTD Mettler-Toledo International	Hold	19	53%	$170.43	-88.5%
WST West Pharmaceutical Services	Strong Buy	23	91%	$136.24	-62.7%